Children’s Tumor Foundation President Annette Bakker was published in STAT, the influential life sciences publication, on a critical topic: gaining access to shelved drugs that could help NF patients and others. In this article, Dr. Bakker explores the opportunities for pharma/biotech to release drugs that can both help patients as well as benefit the companies. She writes: “Repurposing shelved drugs that have already been proven safe in humans can save companies millions of dollars and years of research and development, allowing potential treatments to reach kids — and adults — with cancer and other diseases as quickly as possible.”
Click here to read the article featured in STAT.
